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Abstract 
 
Background 
Pre-eclampsia is a serious complication of pregnancy and contributes to maternal 
and offspring mortality and morbidity.  Randomised controlled trials evaluating 
therapeutic interventions for pre-eclampsia have reported many different outcomes 
and outcome measures. Such variation contributes to an inability to compare, 
contrast, and combine individual studies, limiting the usefulness of research to inform 
clinical practice. The development and use of a core outcome set would help to 
address these issues ensuring outcomes important to all stakeholders, including 
patients, will be collected and reported in a standardised fashion. 
 
Methods 
An international steering group including healthcare professionals, researchers, and 
patients, has been formed to guide the development of this core outcome set. 
Potential outcomes will be identified through a comprehensive literature review and 
semi-structured interviews with patients. Potential core outcomes will be entered into 
an international, multi-perspective online Delphi survey. All key stakeholders, 
including healthcare professionals, researchers, and patients will be invited to 
participate. The modified Delphi method encourages whole and stakeholder group 
convergence towards consensus ‘core’ outcomes.  Once core outcomes have been 
agreed upon it is important to determine how they should be measured. The truth, 
discrimination, and feasibility assessment framework will assess the quality of 
potential outcome measures. High quality outcome measures will be associated with 
core outcomes. Mechanisms exist to disseminate and implement the resulting core 
outcome set within an international context. 
 
Discussion 
Embedding the core outcome set within future clinical trials, systematic reviews, and 
clinical practice guidelines could make a profound contribution to advancing the 
usefulness of research to inform clinical practice, enhance patient care, and improve 
maternal and offspring outcomes.  The infrastructure created by developing a core 
outcome set for pre-eclampsia could be leveraged in other settings, for example 
selecting research priorities and clinical practice guideline development. 
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Prospective registration  
[1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 
588. 
[2] International Prospective Register of Systematic Reviews (PROSPERO) 
registration number: CRD42015015529. 
 
Keywords 
[1] Pre-eclampsia. 
[2] Core outcome set. 
[3] Systematic review. 
[4] Semi-structured interviews. 
[5] Modified Delphi method. 
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Background 
Pre-eclampsia is an enigmatic pregnancy specific, multisystem syndrome 
characterised by reduced organ perfusion secondary to vasospasm and activation of 
the coagulation cascade. Despite extensive research, the cause of pre-eclampsia 
remains elusive. There is no international consensus regarding the diagnostic criteria 
for pre-eclampsia.  The International Society for the Study of Hypertension in 
Pregnancy (ISSHP) defines pre-eclampsia as new onset hypertension (≥140 mmHg 
systolic or ≥90 mmHg diastolic) developing after 20 weeks gestation presenting with 
new-onset proteinuria, other maternal organ dysfunction, and / or uteroplacental 
dysfunction.1 Pre-eclampsia is associated with maternal and offspring mortality and 
morbidity, especially in cases where severe features are present.2 The development 
of therapeutic interventions to reduce this health burden is urgently required. 
 
Selecting appropriate outcomes to reflect beneficial and harmful effects is a critical 
step in designing clinical studies. To ensure relevance to policy and practice the 
chosen outcomes need to be relevant to key stakeholders, including healthcare 
professionals, researchers, and patients. In the absence of a standardised approach 
important outcomes may not be routinely collected and reported. Even in the unlikely 
situation where outcomes have been consistently collected across studies, evidence 
synthesis can be limited by the use of different outcome measures (including 
definitions and instruments). For example, severe pre-eclampsia has been defined 
using different blood pressure thresholds, proteinuria thresholds, clinical symptoms, 
placental parameters, and fetal parameters.3  The development and use of a 
collection of well-defined, discriminatory, and feasible outcomes, termed a core 
outcome set, would help to address these issues.4 
 
Core outcome sets are agreed minimum sets of outcomes that can be measured in a 
standardised manner and reported consistently in the final publication.4  They do not 
necessarily need to be extensive and represent a minimum data set. Researchers 
remain free to measure other outcomes in addition.  We aim to replicate the success 
of the Outcome Measures in Rheumatology (OMERACT) initiative. This initiative has 
developed core outcome sets for many different conditions. Successful 
implementation of the rheumatoid arthritis core outcome set has resulted in a 
significant change in the quality and relevance of research and enriched clinical 
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practice by identifying consensus outcomes which are now routinely monitored by 
healthcare professionals and patients around the world.5 
 
A recent international initiative has developed a core outcome set for randomised 
trials evaluating interventions for asymptomatic preterm birth.6 One hundred and 
seventy-four individuals, representing five stakeholder groups, including 
obstetricians, midwives, neonatologists, researchers, and patients, from twenty-five 
countries participated in a modified Delphi method.  The method was able to reduce 
227 outcomes identified by a systematic review of the literature and 33 outcomes 
suggested by participants to 13 consensus ‘core’ outcomes.  Consensus was 
reached on four outcomes related to pregnant women: [1] maternal mortality; [2] 
maternal infection or inflammation; [3] preterm rupture of membranes; and [4] harm 
to mother from intervention.  Consensus was reached on nine outcomes related to 
the offspring: [1] gestational age at delivery; [2] offspring mortality; [3] birthweight; [4] 
early neurodevelopmental morbidity; [5] late neurodevelopmental morbidity; [6] 
gastrointestinal morbidity; [7] infectious morbidity; [8] respiratory morbidity; and [9] 
harm to offspring from intervention.6 
 
The objective of this study is to produce, disseminate, and implement a core 
outcome set for pre-eclampsia. 
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Methods 
 
Prospective Registration 
The Core Outcome Measures in Effectiveness Trials (COMET) initiative brings 
together researchers interested in the development, application, and promotion of 
core outcome sets. The study has been prospectively registered with the COMET 
initiative, the registration number is 588, and the International Prospective Register 
of Systematic Reviews (PROSPERO), the registration number is CRD42015015529. 
We will follow reporting guidelines for systematic reviews, as outlined by the 
referred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement.7  
 
Ethical Review 
Approval for the qualitative patient interviews has been obtained from the National 
Research Ethics Service (NRES) Committee South Central ethics committee 
(reference number: 12/SC/0495) and all participants will be requested to provide 
informed written consent. The NRES has advised that the Delphi survey does not 
require ethical approval. 
 
Study Funding 
This study is funded by the National Institute for Health Research (reference: DRF-
2014-07-051).  The funder has no role in the design and conduct of the study, the 
collection, management, analysis, or interpretation of data, or manuscript 
preparation. 
 
Steering Group and Study Management Group 
An international steering group, including healthcare professionals, researchers, and 
patient representatives, has been formed to guide the development of this core 
outcome set.  Members of the steering group have been selected to represent 
various disciplines, geographical areas, and expertise.   Within the steering group a 
study management group has been established.  The study management group 
consists of a study coordinator (JD) and three members of the steering group (KK, 
RM, and SZ) who will conduct the day-to-day management of the study. 
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Scope of this Core Outcome Set 
The steering group recommended the core outcome set should apply to clinical 
studies evaluating therapeutic interventions for women with pre-eclampsia.  All 
therapeutic interventions for pre-eclampsia will be considered regardless of type, 
setting, or mode of administration. In order to maximise generalisability, we will not 
differentiate between early and late onset or mild and severe pre-eclampsia. Pre-
eclampsia will be defined as new onset hypertension (≥140 mmHg systolic or ≥90 
mmHg diastolic) after 20 weeks gestation presenting with new-onset proteinuria, 
other maternal organ dysfunction, or uteroplacental dysfunction.1 
 
We are not seeking to reach consensus regarding the definition of pre-eclampsia, 
the standardisation of other aspects of study design, or the development of a 
standardised database for perinatal research studies.  We acknowledge the work of 
the Global Pregnancy Collaboration and the International Society for the Study of 
Hypertension in Pregnancy (ISSHP) in these areas.1&8  We are actively collaborating 
with their efforts. 
 
Endorsement 
iHOPE is endorsed and supported by prominent national and international 
organisations including: [1] Action on Pre-eclampsia (APEC); [2] British Hypertension 
Society; [3] Core Outcomes in Women’s Health (CROWN) initiative; [4] Global 
Obstetrics Network (GONet); [5] Global Pregnancy Collaboration (GONet); [6] 
International Society for the Study of Hypertension in Pregnancy (ISSHP); [7] 
Obstetric Anaesthetists Association; and [8] Pre-eclampsia-Eclampsia Monitoring, 
Prevention and Treatment (PRE-EMPT) initiative.  
 
Study Overview 
The study will be divided into three distinct stages: [1] identifying potential core 
outcomes; [2] determining core outcomes; and [3] determining how core outcomes 
should be measured (figure 1). 
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Stage One: Identifying Potential Core Outcomes 
 
Systematic review: what outcomes have been reported before? 
The Cochrane Central Register of Controlled Trials (CENTRAL) is a highly 
concentrated source of randomised controlled trials reports (RCT) identified by 
searching other bibliographical databases, including EMBASE and Medline, and 
other sources. We will search CENTRAL to identify trials evaluating therapeutic 
interventions for pre-eclampsia. The screening of the records retrieved will be 
performed in duplicate and disagreements will be resolved by discussion. No date or 
language restrictions will be applied, and translations will be obtained for non-English 
language reports. Full text reports will be reviewed for eligible studies and data will 
be extracted in duplicate using a standardised and piloted data extraction proforma 
recording study and outcome reporting characteristics.  Disagreements will be 
resolved by discussion. Individual outcomes will be entered into the outcome 
inventory. 
 
Qualitative patient Interviews: what outcomes do patients want? 
Patients often identify outcomes not considered by other stakeholders or within the 
literature.4  Women with lived experience of pre-eclampsia will be recruited to 
participate in qualitative interviews through National Health Service (NHS) clinics, the 
patient support group Action on Pre-eclampsia, and through social media.  Potential 
participants will be asked to complete a recruitment questionnaire recording 
demographic details and information pertaining to their lived experiences of pre-
eclampsia. We do not intend to interview all those who volunteer, but will select 
participants to deliver a maximum diversity sample.  After obtaining informed 
consent, participants will be interviewed in a setting of their choice, usually their 
home.  Interview questions were developed in consultation with the steering group 
and guided by the literature review. The interview will start with an open-ended 
narrative section followed by a semi structured section with questions exploring their 
lived experience. The interviews will be audio or video recorded and transcribed 
verbatim. 
 
Data collection and analysis will be guided by a modified grounded theory approach, 
allowing data analysis of early interviews to enrich data collection of latter 
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interviews.9  These data will be analysed in consultation with a second experienced 
qualitative researcher using both a systematic approach of coding managed in NVivo 
10 (QSR International, USA) and Framework to aid contextual understanding.10 Data 
analysis will identify outcomes to be entered into the outcome inventory. The wording 
of outcomes will be grounded in the interview data and will be decided in 
collaboration with the patient representatives.  Data saturation will be achieved when 
no new substantive themes are being identified through the analysis. 
 
Outcome inventory 
A comprehensive inventory of outcomes identified by the systematic review and 
analysis of the qualitative interviews will be produced.  If there is uncertainty as to 
how to classify or present an outcome the advice of the steering group will be 
sought. Following the steering group's agreement, the outcome inventory will be 
entered into the modified Delphi method. 
 
Stage Two: Determining Core Outcomes  
Combining professional and patients’ views. 
The modified Delphi methods enables key stakeholders to participate in a process 
which assesses the extent of agreement (consensus measurement) and then 
resolves disagreement (consensus development).11 All key stakeholders including 
healthcare professionals (anaesthetists, general practitioners, obstetricians, 
midwives, and neonatologists), researchers, and patients will be invited to 
participate. There is no robust method for calculating the required sample size but 
typically groups have included 13 to 222 participants.11 We aim to recruit a minimum 
of 18 participants for each stakeholder group (anaesthetists, general practitioners, 
obstetricians, midwives, neonatologists, researchers, and patients) with balanced 
representation from high, middle, and low income countries.  Before entering the 
exercise participants will be allocated a unique identifier to anonymise their 
response. The online Delphi survey will be developed to ensure the ease of 
completion utilising appropriate patient terminology. Lay definitions will be available 
for individual outcomes. The survey will be piloted by the steering group before its 
use. 
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Round one 
Participants will be invited to score individual outcomes on a nine point Likert scale 
anchored between one (labelled ‘of limited importance for making a decision’) and 
nine (labelled ‘critical for making a decision’). This scale was devised by the Grading 
of Recommendations Assessment, Development and Evaluation (GRADE) working 
group to facilitate the ranking of outcomes according to their importance and has 
been adopted widely by core outcome set developers.12  Participants will be 
presented with the opportunity to add additional outcomes before completing the 
survey. Additional outcomes listed by participants will be reviewed and coded by the 
outcome committee and incorporated into round two. 
 
Round two 
All outcomes will be carried forward from round one into round two. For each 
outcome, the percentage of participants scoring individual outcomes during round 
one at each possible response from one to nine will be calculated and tabulated for 
each individual stakeholder group (healthcare professional, researchers, and 
patients).   Participants will be able to view the results of individual stakeholder 
groups.  Participants will be invited to rescore individual outcomes. The modified 
Delphi method promotes repeated reflection and rescoring promoting whole and 
stakeholder group convergence upon consensus “core” outcomes.10 
 
A standardised definition will be applied to this round’s results enabling core 
outcomes to be identified: 
[1] Consensus in (classify as a core outcome): Over 70% of participants in each 
stakeholder group score outcome 'critical for decision making' (score seven to nine) 
and less than 15% of participants in each stakeholder group score outcome 'of 
limited importance for decision making' (score one to three). 
[2] Consensus out (do not classify as a core outcome): Over 70% of participants in 
each stakeholder group score outcome domain 'of limited importance for decision 
making' (score one to three) and less than 15% of participants in each stakeholder 
group score outcome domain 'critical for decision making' (score seven to nine); or 
[3] No Consensus (do not classify as a core outcome): Anything else. 
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The round two results will be reviewed by the steering group to consider the need for 
a further Delphi survey round. 
 
Consensus meeting 
The results from the modified Delphi method will be considered within a consensus 
meeting. The meeting will include a range of views from participants that will be 
purposefully sampled. The objective of the consensus meeting will be to discuss 
outcomes not reaching consensus and approve a final core outcome set for pre-
eclampsia. To ensure unbiased consensus formation amongst a group of varied 
participants, the steering committee will ensure that the meeting is informal, 
inclusive, participatory and values all opinions. 
 
Stage Three: Determining How Core Outcomes Should Be Measured 
Ensuring outcome measures fit for purpose. 
Once core outcomes are agreed upon it will be important to determine how the 
outcomes should be defined and measured. Currently no guidelines are available to 
support outcome measurement instrument selection.  The Core Outcome 
Measurement Instrument Selection (COMIS) project is in the process of developing 
standard for assessing the methodological quality of studies exploring the 
measurement properties of instruments.13  We will assess potential instruments 
using the developed framework. The assessment will be undertaken in duplicate 
using a standardised and piloted data extraction proforma. If there is disagreement 
or uncertainty as to how to classify an outcome measurement the advice of the 
steering group will be sought. High quality outcome measures will be associated with 
each core outcome. The study will not advocate the use of a single outcome 
measure if several high quality outcome measures are identified for a single 
outcome. If no high quality outcome measures exist for a core outcome this will be 
acknowledged. 
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Discussion 
Implementing core outcome sets in future clinical studies, systematic reviews, and 
clinical guidelines could make a profound contribution to advancing the reach and 
relevance of research in informing clinical practice, enhancing patient care, and 
improving maternal and offspring outcomes. 
 
Improving clinical trial outcome selection. The Standard Protocol Items: 
Recommendations for Interventional Trials (SPIRIT) statement, supported by funders 
of health research, recommend the use of core outcome sets where they exist.14 A 
core outcome set would ensure consensus outcomes important to all stakeholders, 
including patients, are collected and reported. When clinical studies use consensus 
outcomes and outcome measures prospective meta-analysis using individual patient 
data is feasible. 
 
Improving clinical trial reporting and evidence synthesis.  The Core Outcomes in 
Women’s Health (CROWN) initiative, supported by 74 speciality journals, including 
the Cochrane Pregnancy and Childbirth Group, has resolved to implement core 
outcome sets.15 Participating journals will require authors to report the results for 
core outcomes within trial reports and systematic reviews and offer conclusions 
based on these outcomes rather than non-core or surrogate outcomes. Where core 
outcome sets have not been collected the authors will be asked to report this 
deficiency and its implications for their findings.15  
 
Improving clinical practice guidelines.  The National Institute for Health and Care 
Excellence (NICE) supports the use of core outcomes sets when selecting outcomes 
during evidence scoping and synthesis.  As this activity forms the basis of updating 
guideline recommendations the core outcome set could have a direct impact in 
influencing clinical practice.   
 
Developing infrastructure to support international collaboration. Developing a core 
outcome set will establish an international network of key stakeholders, including 
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healthcare professionals, researchers, and patients, with experience of contributing 
to a collaborative online study. This infrastructure could be leveraged in other 
settings, for example selecting research priorities and clinical practice guideline 
development. 
 
Conclusion 
Embedding the core outcome set within future clinical trials, systematic reviews, and 
clinical practice guidelines could make a profound contribution to advancing the 
usefulness of research to inform clinical practice, enhance patient care, and improve 
maternal and offspring outcomes.  The infrastructure created by developing a core 
outcome set for pre-eclampsia could be leveraged in other settings, for example 
selecting research priorities and clinical practice guideline development. 
 
Box 1: How do I contribute to improving pre-eclampsia research? 
We acknowledge the expertise and commitment of this journals’ readership to 
improving patient care. We warmly invite readers to participate in the modified Delphi 
survey by registering their interest to participate here: www.phc.ox.ac.uk/ihope 
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Figure 1. Study outline. 
Caption: Developing a core outcome set for Pre-eclampsia. 
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